Jeffrey Meyerhardt

46PUBLICATIONS
296CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyMolecular targetsPredictive and prognostic markersContext learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 01, 2026
A Phase II Study of Nivolumab and Ipilimumab with Radiation Therapy in Patients with Metastatic, Microsatellite Stable Colorectal Cancer.

|Jul 08, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

|Jul 07, 2026
Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials.

|Apr 29, 2026
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Mar 26, 2026
Tumor vessel phenotype in colorectal cancer microenvironment according to age at diagnosis.

Kosuke Matsuda, Satoko Ugai, Satoshi Miyahara

|Dec 19, 2025
Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.

Carino Gurjao, Jules Cazaubiel, Chichun Tan

Pageof 8

Frequent Collaborators

13 joint publications

Eileen O'Reilly

10 joint publications

Kimmie Ng

10 joint publications

Qian Shi

10 joint publications

Shuji Ogino